Αυγ262015Βιβλιογραφικά δεδομέναΓια να δείτε το άρθρο πιέστε εδώ Κατηγορία Βιβλιογραφικά δεδομένα26 Αυγούστου 2015 Μοιραστείτε το! Share on FacebookShare on Facebook Share on XShare on X Share on LinkedInShare on LinkedIn Share on WhatsAppShare on WhatsApp Post navigationΠροηγούμενοPrevious post:Toward a More Complete Understanding of the Association Between a Hepatitis C Sustained Viral Response and Cause-Specific OutcomesΕπόμενοNext post:The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infectionΣχετικά ΆρθραLiver transplantation is the major determinant of > 10-year survival in patients with hepatocellular carcinoma14 Μαΐου 2026Geographic disparities in hepatitis B vaccine coverage across Africa: Implications for targeted interventions and 2030 goals8 Μαΐου 2026Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis6 Μαΐου 2026Risk of de novo HCC in patients with MASLD following direct-acting antiviral – induced cure of HCV infection24 Απριλίου 2026Prognostic significance of mild ascites in patients with cirrhosis14 Απριλίου 2026The Rise of Transplant Oncology in Primary Liver Cancer and Metastatic Disease10 Μαρτίου 2026
Liver transplantation is the major determinant of > 10-year survival in patients with hepatocellular carcinoma14 Μαΐου 2026
Geographic disparities in hepatitis B vaccine coverage across Africa: Implications for targeted interventions and 2030 goals8 Μαΐου 2026
Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis6 Μαΐου 2026
Risk of de novo HCC in patients with MASLD following direct-acting antiviral – induced cure of HCV infection24 Απριλίου 2026
